GB0908685D0 - Composition for intraocular delivery - Google Patents

Composition for intraocular delivery

Info

Publication number
GB0908685D0
GB0908685D0 GBGB0908685.1A GB0908685A GB0908685D0 GB 0908685 D0 GB0908685 D0 GB 0908685D0 GB 0908685 A GB0908685 A GB 0908685A GB 0908685 D0 GB0908685 D0 GB 0908685D0
Authority
GB
United Kingdom
Prior art keywords
composition
intraocular delivery
intraocular
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0908685.1A
Other versions
GB2470378A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Westminster
Original Assignee
University of Westminster
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Westminster filed Critical University of Westminster
Priority to GB0908685A priority Critical patent/GB2470378A/en
Publication of GB0908685D0 publication Critical patent/GB0908685D0/en
Priority to PCT/EP2010/003120 priority patent/WO2010133374A2/en
Publication of GB2470378A publication Critical patent/GB2470378A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
GB0908685A 2009-05-20 2009-05-20 A controlled release composition for intraocular delivery of a therapeutic agent Withdrawn GB2470378A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0908685A GB2470378A (en) 2009-05-20 2009-05-20 A controlled release composition for intraocular delivery of a therapeutic agent
PCT/EP2010/003120 WO2010133374A2 (en) 2009-05-20 2010-05-20 Therapeutic composition comprising microspheres

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0908685A GB2470378A (en) 2009-05-20 2009-05-20 A controlled release composition for intraocular delivery of a therapeutic agent

Publications (2)

Publication Number Publication Date
GB0908685D0 true GB0908685D0 (en) 2009-07-01
GB2470378A GB2470378A (en) 2010-11-24

Family

ID=40862699

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0908685A Withdrawn GB2470378A (en) 2009-05-20 2009-05-20 A controlled release composition for intraocular delivery of a therapeutic agent

Country Status (2)

Country Link
GB (1) GB2470378A (en)
WO (1) WO2010133374A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3121353B1 (en) * 2021-03-31 2024-03-22 Chanel Parfums Beaute Cosmetic composition comprising at least one polyhydroxyalkanoate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3428372A1 (en) * 1984-08-01 1986-02-13 Hoechst Ag, 6230 Frankfurt CONTROLLED RELEASE REGULAR PEPTIDES MICROCAPSULES, PRODUCTION METHOD AND INJECTION PREPARATIONS
NZ224549A (en) * 1987-05-29 1990-04-26 Ici Australia Operations Controlled release polymer microspheres containing at least one active agent
FR2693905B1 (en) * 1992-07-27 1994-09-02 Rhone Merieux Process for the preparation of microspheres for the sustained release of the hormone LHRH and its analogs, microspheres and formulations obtained.
US6447796B1 (en) * 1994-05-16 2002-09-10 The United States Of America As Represented By The Secretary Of The Army Sustained release hydrophobic bioactive PLGA microspheres
CA2368470C (en) * 1999-03-25 2011-05-17 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
EP1651273B1 (en) * 2003-07-08 2012-08-29 Tepha, Inc. Poly-4-hydroxybutyrate matrices for sustained drug delivery
JP2008512350A (en) * 2004-07-01 2008-04-24 イェール ユニバーシティ Polymeric substances that are targeted and loaded with drugs at high density
US8168584B2 (en) * 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
WO2007130134A2 (en) * 2005-12-02 2007-11-15 (Osi) Eyetech, Inc. Controlled release microparticles
US8969415B2 (en) * 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US8492334B2 (en) * 2007-06-21 2013-07-23 Yale University Sustained intraocular delivery of drugs from biodegradable polymeric microparticles

Also Published As

Publication number Publication date
WO2010133374A3 (en) 2011-01-13
WO2010133374A2 (en) 2010-11-25
GB2470378A (en) 2010-11-24

Similar Documents

Publication Publication Date Title
IL215608A0 (en) Drug delivery composition
GB0908129D0 (en) Composition
GB0918450D0 (en) Composition
HUE042850T2 (en) Compositions for drug delivery
GB0911428D0 (en) Composition
ZA201107839B (en) Composition
ZA201107838B (en) Composition
IL216081A (en) Pharmaceutical composition for reducing intraocular pressure
GB0909362D0 (en) Composition
PL2393887T3 (en) Composition
GB0908642D0 (en) Composition
ZA201106651B (en) Composition comprising delivery particles
GB0906779D0 (en) Composition
GB0904941D0 (en) Composition
GB0922389D0 (en) composition
EP2444061A4 (en) Apigenin-containing composition
GB201006350D0 (en) Composition
GB0911294D0 (en) Composition
GB0904942D0 (en) Composition
GB0918590D0 (en) Composition
GB0903688D0 (en) Composition
GB0908685D0 (en) Composition for intraocular delivery
GB0917792D0 (en) Delivery agent
GB0922133D0 (en) Composition
GB0902959D0 (en) Composition

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)